DAIC Articles

May 23, 2018 | DAIC Articles
Renal Denervation Shows Significant Drop in Hypertension

“At the 2018 EuroPCR Annual Meeting in Paris, Medtronic plc announced first-ever-data from the SPYRAL HTN-ON MED Study.”

May 22, 2018 | DAIC Articles
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR

“Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for vessel Fractional Flow Reserve) software will be presented during EuroPCR 2018, May 22-25 in Paris, France.”

May 21, 2018 | DAIC Articles
Medtronic MindFrame Capture LP Revascularization Device Recalled

“Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device Recall of the MindFrame Capture LP revascularization device on account of a risk of the delivery wire breaking or separating during use.”

May 21, 2018 | DAIC Articles
Five Key Takeaways From Heart Rhythm 2018

“Electrophysiology is one of the most rapidly-growing areas of healthcare. That may be why it’s the focus of so many industry events including the Heart Rhythm Society’s annual conference.”

May 21, 2018 | DAIC Articles
Radiofrequency Transseptal Needle Associated With 40 Percent Decrease in Silent Cerebral Embolism

“A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40 percent lower incidence of silent acute cerebral embolism in atrial fibrillation (AF) ablation procedure patients.[1] “

May 21, 2018 | DAIC Articles
Innovative Health Receives FDA Clearance to Reprocess the ViewFlex Xtra Diagnostic Ultrasound Catheter

“Cardiology medical device reprocessing company Innovative Health recently received U.S. Food and Drug Administration (FDA) clearance to reprocess the Abbott ViewFlex Xtra Diagnostic Ultrasound Catheter.”

May 18, 2018 | DAIC Articles
Cardiac Contractility Modulation Safe and Effective as Heart Failure Treatment

“In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve exercise tolerance (ET) and quality of life (QoL) for patients with persistent symptomatic heart failure and an ejection fraction between 25 and 45 percent.”

May 18, 2018 | DAIC Articles
ENHANCE CRT Pilot Study Evaluates Alternative Approach for Non-Left Bundle Branch Block Patients

“Data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with non-left bundle branch block (non-LBBB) is limited and when available has been shown to be suboptimal compared to LBBB patients.”

May 16, 2018 | DAIC Articles
V-Wave Closes $70M Financing to Support Pivotal Study of Heart Failure Therapy

“Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF).”

May 15, 2018 | DAIC Articles
Culprit Vessel Only Strategy Has Lower Mortality Than Routine Multivessel Intervention

“A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used for patients with multivessel disease (MVD) and acute myocardial infarction (AMI) with cardiogenic shock (CS).”